Literature DB >> 1729250

Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene.

J Yother1, G L Handsome, D E Briles.   

Abstract

Insertion-duplication mutagenesis was used to generate mutants of Streptococcus pneumoniae that produced truncated forms of PspA (pneumococcal surface protein A). The truncated products, representing from 20 to 80% of the complete PspA molecule, were all secreted from the cell and could be detected in unconcentrated culture medium. Analysis of the truncated molecules showed that the antigenic variability known to be associated with PspA is located in the alpha-helical N-terminal half of the molecule. This region was also found to contain immunogenic and protection-eliciting epitopes and to define the maximum region of the molecule that is likely to be surface exposed. The apparent molecular weight variability seen for PspA molecules of different S. pneumoniae strains was localized to both the N- and C-terminal halves of the protein. Attachment of PspA to S. pneumoniae was found to require regions located carboxy to the fifth repeat unit in the C-terminal end of the molecule. From the insertion-duplication mutants, the complete pspA gene was cloned and expressed in Escherichia coli. Differences in apparent molecular weight were observed when the same cloned product was expressed in E. coli and S. pneumoniae, suggesting that PspA is modified differently in the two hosts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729250      PMCID: PMC205756          DOI: 10.1128/jb.174.2.610-618.1992

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  26 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis.

Authors:  J Yother; D E Briles
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

3.  Cloning specific segments of the mammalian genome: bacteriophage lambda containing mouse globin and surrounding gene sequences.

Authors:  S M Tilghman; D C Tiemeier; F Polsky; M H Edgell; J G Seidman; A Leder; L W Enquist; B Norman; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

4.  Transformation of encapsulated Streptococcus pneumoniae.

Authors:  J Yother; L S McDaniel; D E Briles
Journal:  J Bacteriol       Date:  1986-12       Impact factor: 3.490

5.  Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells.

Authors:  M Dagert; S D Ehrlich
Journal:  Gene       Date:  1979-05       Impact factor: 3.688

6.  Destruction of low efficiency markers is a slow process occurring at a heteroduplex stage of transformation.

Authors:  N B Shoemaker; W R Guild
Journal:  Mol Gen Genet       Date:  1974

7.  A 43-kilodalton pneumococcal surface protein, PspA: isolation, protective abilities, and structural analysis of the amino-terminal sequence.

Authors:  D F Talkington; D L Crimmins; D C Voellinger; J Yother; D E Briles
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

8.  Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.

Authors:  D E Briles; M Nahm; K Schroer; J Davie; P Baker; J Kearney; R Barletta
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

9.  Rapid cloning of specific DNA fragments of Streptococcus pneumoniae by vector integration into the chromosome followed by endonucleolytic excision.

Authors:  V Méjean; J P Claverys; H Vasseghi; A M Sicard
Journal:  Gene       Date:  1981-11       Impact factor: 3.688

10.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

View more
  66 in total

1.  Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.

Authors:  A H Tu; R L Fulgham; M A McCrory; D E Briles; A J Szalai
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Cloning of fibA, encoding an immunogenic subunit of the fibril-like surface structure of Peptostreptococcus micros.

Authors:  B H Kremer; J J Bijlsma; J G Kusters; J de Graaff; T J van Steenbergen
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

3.  Contribution of choline-binding proteins to cell surface properties of Streptococcus pneumoniae.

Authors:  Edwin Swiatlo; Franklin R Champlin; Steven C Holman; W William Wilson; James M Watt
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Immunization with truncated recombinant protein SpaC of Erysipelothrix rhusiopathiae strain 715 serovar 18 confers protective immunity against challenge with various serovars.

Authors:  Ho To; Shuichi Someno; Shinya Nagai; Tomohiro Koyama; Tetsuji Nagano
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

5.  Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.

Authors:  Melanie Abeyta; Gail G Hardy; Janet Yother
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

6.  Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.

Authors:  Bing Ren; Alexander J Szalai; Orlanda Thomas; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

7.  PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].

Authors:  Mirza Shaper; Susan K Hollingshead; William H Benjamin; David E Briles
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Crystallization and preliminary X-ray diffraction studies of choline-binding protein F from Streptococcus pneumoniae.

Authors:  Rafael Molina; Ana González; Miriam Moscoso; Pedro García; Meike Stelter; Richard Kahn; Juan A Hermoso
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-08-10

9.  Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface.

Authors:  Bing Ren; Alexander J Szalai; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Biochemical activities of Streptococcus pneumoniae serotype 2 capsular glycosyltransferases and significance of suppressor mutations affecting the initiating glycosyltransferase Cps2E.

Authors:  David B A James; Kanupriya Gupta; Jocelyn R Hauser; Janet Yother
Journal:  J Bacteriol       Date:  2013-10-04       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.